Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,878,545 shares of SUPN stock, worth $95.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,878,545
Previous 2,882,505
0.14%
Holding current value
$95.1 Million
Previous $89.9 Million
15.81%
% of portfolio
0.03%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.6MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$343 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$203 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$160 Million2.47% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$86.9 Million0.11% of portfolio
-
State Street Corp Boston, MA2.19MShares$72.3 Million0.0% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.77B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...